Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels

Nonalcoholic fatty liver disease (NAFLD) patients with diabetes constitute a subgroup of patients with a high rate of liver-related complications. Currently, there are no specific drug recommendations for these patients. Metformin, a conventional insulin sensitizer agent, has been widely prescribed...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinyopornpanish, Kanokwan, Leerapun, Apinya, Pinyopornpanish, Kanokporn, Chattipakorn, Nipon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593497/
https://www.ncbi.nlm.nih.gov/pubmed/33820884
http://dx.doi.org/10.5009/gnl20367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593497/
https://www.ncbi.nlm.nih.gov/pubmed/33820884
http://dx.doi.org/10.5009/gnl20367

Ejemplares similares